Aveanna Healthcare Holdings

Aveanna Healthcare Holdings, Inc. operates as a holding company. The firm, through its subsidiaries, provides pediatric home care services. It offers pediatric therapy, adult skilled nursing, and medical services. The company was founded on November 30, 2016 and is headquartered in Atlanta, GA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Aveanna Healthcare reports Q4 growth, eyes rate increases for 2023

Aveanna Healthcare's Q4 performance showed revenue growth but a decrease in adjusted EBITDA due to labor costs.
The company aims to drive growth in 2023 through rate increases, expanding preferred payers, and optimizing staffing rates.
Challenges include caregiver supply, cash flow turnaround, and potential hurdles in passing rate increases in key states.

Aveanna Healthcare reports revenue growth, legal wins, and cash flow focus

Aveanna Healthcare Holdings navigated Q1 with revenue growth, cost challenges, and legal wins, aiming for positive cash flows in the second half.
The company's focus on caregiver recruitment, preferred payer relationships, and strategic investments positions them for growth despite industry concerns.
While facing regulatory uncertainties and cash flow challenges, Aveanna's strong liquidity and operational strategies provide a foundation for future success.

Aveanna Healthcare reports revenue growth and strategic payer mix focus

Aveanna Healthcare Holdings demonstrated solid financial performance in Q2 2023, with revenue growth and increased EBITDA, despite challenges in the labor market.
The company's strategic focus on preferred payer mix, rate negotiations, and advocacy efforts positions it well for future growth and financial stability.
While facing operational challenges and ongoing negotiations, Aveanna's proactive approach to revenue optimization and advocacy bodes well for long-term success.
Maintaining liquidity, raising revenue guidance, and emphasizing alignment with value-based payers underscore Aveanna's commitment to financial resilience and growth.

Aveanna Healthcare reports strong Q3 performance amidst industry challenges

Aveanna Healthcare Holdings delivered a robust performance in Q3, showcasing revenue growth, improved margins, and enhanced EBITDA, despite industry challenges.
The company's strategic focus on rate increases, preferred payers, and maintaining liquidity positions it well for sustained growth and financial stability.
While facing challenges like caregiver shortages and wage inflation, Aveanna's positive outlook and disciplined approach signal opportunities for future growth and profitability.

Aveanna Healthcare reports robust Q4 earnings and outlines growth strategies

Aveanna Healthcare Holdings demonstrated strong financial performance in Q4 2023 and full year 2023, with revenue and adjusted EBITDA showing significant growth.
The company's strategic initiatives, focus on preferred payers, and plans for margin expansion in 2024 position Aveanna for continued success and growth.
While facing challenges in the labor market and payer dynamics, Aveanna's emphasis on cost efficiencies and capital management presents opportunities for sustained profitability and market competitiveness.

Aveanna Healthcare reports strong Q1 growth, eyes sustained revenue

Aveanna Healthcare Holdings' Q1 2024 performance reflects revenue and EBITDA growth driven by strategic initiatives and operational strengths.
While facing challenges in securing rate increases and managing cost efficiencies, Aveanna is well-positioned to capitalize on opportunities for sustained growth.
With a focus on partnerships, caregiver capacity enhancements, and financial stability, Aveanna is poised for continued success and operational excellence.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Aveanna Healthcare Holdings, Inc. engages in providing home care services to patients. It operates through the following business segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing services. The HHH segment provides home health, hospice, and program services to predominately elderly populations. The MS segment offers supplies to patients requiring enteral nutrition services or respiratory care. The company was founded on November 30, 2016 and is headquartered in Atlanta, GA.

Aveanna (AVAH) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Down -17.59% in 4 Weeks, Here's Why You Should You Buy the Dip in Aveanna (AVAH)

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH ) Q3 2024 Earnings Conference Call November 7, 2024 10:00 AM ET Company Participants Debbie Stewart - Chief Accounting Officer Jeff Shaner - Chief Executive Officer Matt Buckhalter - Chief Financial Officer Conference Call Participants Ben Hendrix - RBC Capital Markets Pito Chickering - Deutsche Bank Brian Tanquilut - Jefferies Grayson McAlister - Truist Securities Operator Good morning, and welcome to the Aveanna Healthcare Holdings Third Quarter 2024 Earnings Conference Call. Today's call is being recorded and we have allocated one hour for prepared remarks and Q&A.

Aveanna Healthcare Holdings Inc. (AVAH) Q3 2024 Earnings Call Transcript

Although the revenue and EPS for Aveanna (AVAH) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Aveanna (AVAH) Reports Q3 Earnings: What Key Metrics Have to Say

Aveanna Healthcare (AVAH) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to loss of $0.03 per share a year ago.

Aveanna Healthcare (AVAH) Surpasses Q3 Earnings and Revenue Estimates

ATLANTA, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three and nine-month periods September 28, 2024.

Aveanna Healthcare Holdings Announces Third Quarter 2024 Financial Results and Revised 2024 Outlook

ATLANTA, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Brent Layton to serve as a Class III director of the Board of Directors of Aveanna Healthcare Holdings Inc., and additionally as a member of the Audit Committee of the Board, effective November 1, 2024.

Aveanna Healthcare Holdings Announces Appointment of New Director

Cava Group, Inc.

Carvana

Kinross Gold

Orla Mining Ltd. 

KGC, ORLA, CVNA, CAVA and AVAH have been added to the Zacks Rank #1 (Strong Buy) List on October 25, 2024.

New Strong Buy Stocks for October 25th

ATLANTA, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Stephens Annual Investment Conference. Management will host virtual 1x1 investor meetings on Friday, November 22, 2024.

Aveanna to Participate Virtually at the Stephens Annual Investment Conference

ATLANTA, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its third quarter results before the market open on Thursday, November 7, 2024, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day.

Aveanna Announces Third Quarter 2024 Earnings Release Date and Conference Call

Here is how Aveanna Healthcare (AVAH) and Cardinal Health (CAH) have performed compared to their sector so far this year.

Is Aveanna Healthcare (AVAH) Stock Outpacing Its Medical Peers This Year?

Does Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let's find out.

Aveanna Healthcare (AVAH) Is Up 2.41% in One Week: What You Should Know

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Aveanna (AVAH) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Fast-paced Momentum Stock Aveanna (AVAH) Is Still Trading at a Bargain

Here is how Aveanna Healthcare (AVAH) and AxoGen (AXGN) have performed compared to their sector so far this year.

Is Aveanna Healthcare (AVAH) Outperforming Other Medical Stocks This Year?

ATLANTA, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Deutsche Bank Annual Leveraged Finance Conference in Scottsdale, AZ on September 24, 2024. Management will host 1x1 investor meetings that day.

Aveanna to Participate at the Deutsche Bank Annual Leveraged Finance Conference

Aveanna (AVAH) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Why Fast-paced Mover Aveanna (AVAH) Is a Great Choice for Value Investors

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?

AVAH stock has the potential to continue its uptrend on the back of a better payer rate environment and its focus on high-paying customers.

Aveanna Stock Rallies 110% in 3 Months: Is It Still Worth Buying?

Are You Looking for a Top Momentum Pick? Why Aveanna Healthcare (AVAH) is a Great Choice

Despite Fast-paced Momentum, Aveanna (AVAH) Is Still a Bargain Stock

Are Investors Undervaluing Aveanna Healthcare (AVAH) Right Now?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH ) Q2 2024 Earnings Call August 8, 2024 10:00 AM ET Company Participants Debbie Stewart - Chief Accounting Officer Jeff Shaner - Chief Executive Officer Matt Buckhalter - Chief Financial Officer Conference Call Participants Ben Hendrix - RBC Scott Fidel - Stephens Inc A.J. Rice - UBS Pito Chickering - Deutsche Bank Operator Good morning and welcome to Aveanna Healthcare Holdings Second Quarter 2024 Earnings Conference Call.

Aveanna Healthcare Holdings Inc. (AVAH) Q2 2024 Earnings Call Transcript

Although the revenue and EPS for Aveanna (AVAH) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Aveanna (AVAH) Reports Q2 Earnings: What Key Metrics Have to Say

Aveanna Healthcare (AVAH) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to loss of $0.02 per share a year ago.

Aveanna Healthcare (AVAH) Beats Q2 Earnings and Revenue Estimates

ATLANTA, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three and six-month periods June 29, 2024.

Aveanna Healthcare Holdings Announces Second Quarter 2024 Financial Results and Revised 2024 Outlook

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Aveanna (AVAH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.

News for Aveanna Healthcare Holdings Stock (AVAH)